stockrowICON PLC
ICLR Healthcare Diagnostics & Research
ICON PLC’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.76% from fiscal 2024.
- Revenue
- −2.86%
- EPS
- +143.2%
- Free cash flow
- −8.01%
- Total debt
- −0.86%
Quarter to September 2026, against a year earlier
Follow ICLR
Alert me
ICON PLC (ICLR) Book value per share
ICON PLC's book value per share at the end of fiscal 2025 was 117×, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was 119×. Over the past ten years it has ranged from 13.0× (fiscal 2015) to 120× (fiscal 2021); the current reading is higher than 91% of that period. ICON PLC ranks 3rd of 49 Diagnostics & Research companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 117× | 2.41% |
| FY2024 | 114× | 1.70% |
| FY2023 | 113× | 7.99% |
| FY2022 | 104× | (13.29%) |
| FY2021 | 120× | 243.41% |
| FY2020 | 35.0× | 13.74% |
| FY2019 | 30.8× | 22.98% |
| FY2018 | 25.0× | 13.73% |
| FY2017 | 22.0× | 28.62% |
| FY2016 | 17.1× | 31.70% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 119× | (2.78%) |
| Jun 2026 | 122× | 0.49% |
| Mar 2026 | 121× | 3.60% |
| Dec 2025 | 117× | (2.83%) |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| ICLR ICON PLC | 119× |
| LH Labcorp Holdings Inc. compare | 109× |
| DGX Quest Diagnostics Incorporated compare | 72.3× |
| CRL Charles River Laboratories International, Inc. compare | 67.6× |
| MEDP Medpace Holdings, Inc. compare | 20.9× |
| ILMN Illumina, Inc. compare | 20.8× |
| QGEN QIAGEN N.V. compare | 16.3× |
| RVTY Revvity Inc. compare | 0.0× |
| GH Guardant Health, Inc. compare | −2.1× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on ICLR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement